Medicaid policies for HIV-related prescription drugs.
Buchanan, Robert J
Date of Pub
Smith, Scott R
As State Medicaid programs become increasingly important sources of payment for acquired immunodeficiency syndrome (AIDS)-related
care, and drug regimens the major weapons available to fight human immunodeficiency virus (HIV)-related illnesses, Medicaid
drug policies will have a substantial impact. State Medicaid programs were surveyed to identify policies on a range of prescription
drug policies affecting these recipients. All Medicaid programs provide prescription drug benefits to all categorically needy
recipients, and about three-fourths of the States provide these benefits to medically needy recipients. However, utilization
limits, copayments, and off-label-use and prior-authorization policies in many States weaken the drug benefit available.
Comparative Study : Cost Sharing : Data Collection : Drug Costs : Eligibility Determination : Health Policy/economics : HIV
Infections/drug therapy/economics : Human : Insurance, Pharmaceutical Services/economics/statistics & numerical data : Medicaid/economics/statistics
& numerical data : Prescriptions, Drug/economics : State Health Plans/economics : Support, U.S. Gov't, P.H.S. : United States